Innovation Works’ Post

Scientific storytelling is not about spinning data. It’s about being clear and contextual.  3D’s team of #science and #communications experts know what it takes to bring your data to life—and communicate a credible and compelling story.  Visiting our website or contact us at info@3Dcommunications.us to learn more. #StrategicCommunications #ScientificStorytelling #pharma #BioTech #MedicalDevice https://lnkd.in/eeVx46ny

Struggling to unlock hidden funding for your biotech startup? Here are 4 alternative sources from a recent session hosted by Victoria Donovan of Clinically Media and Adrian Rubstein of Ax3.Bio with Carter Caldwell of Penn Center for Innovation: 🔍 Dive Deeper into Pharma Venture Arms: Pitch pharma company corporate ventures like SR One Capital Management or Novo Ventures investing in tech that complements their pipelines. 🌟 Connect with Cause via Disease Foundations: Organizations like BrightEdge - American Cancer Society fund mission-driven research. Align your startup with relevant foundations. 🎓 Leverage Legacy through Alumni Investment Networks: Use university connections to tap into alumni investors eager to support new technologies and feedback synergies to the institution's network. 🏙️ Go Local with Investor Groups: Seek out city and regional groups focusing on biotech and medtech investments. Takeaway: Finding overlooked investors isn't just about funding—it's about discovering partners who bring value and connections to propel your vision forward. https://lnkd.in/eAFNCwCF #Biotech #Innovation #StartupFunding #VentureCapital #Entrepreneurship

Have you been impacted by the War on Drugs? The Massachusetts Social Equity Program Application is now open and the Cannabis Control Commission and its Equity Programming and Community Outreach (EPCO) team will host six Application Clinics to support prospective applicants interested in applying for the SEP. When: Saturday, March 9 · 12 - 2pm EST Where: Brockton Public Library, 304 Main Street Brockton, MA 02301 The SEP provides participants with education, skill-based training, and tools for success in the industry across four areas: entrepreneurship, managerial-level workforce development, entry-level workforce development, and ancillary support for businesses that contract with the industry but do not hold a license. The SEP is not a license type. By completing this program, participants will acquire tools and training to help apply for a license through the Cannabis Control Commission if they are interested in owning a Marijuana Establishment or Medical Marijuana Treatment Center. https://lnkd.in/dDptarTq #cannabisindustry #socialequity #education

What are pragmatic clinical trials? In general, pragmatic clinical trials are those clinical trials that can: Focus on efficacy or safety Streamline data collection and study design by collecting only those data truly necessary to answer the research question Use most straightforward endpoint feasible (i.e., overall survival) Decrease burden for trial participants, investigators, and sponsors Incorporate design elements more reflective of routine clinical practice Take advantage of functional efficiencies (e.g., fewer and/or broader and/or less-restrictive eligibility criteria, flexibilities in trial delivery and outcome measurement, etc.) Improve trial participation, increase diversity, facilitate rapid enrollment, reduce attrition Generate evidence representative of the general population affected by the clinical question For more details on pragmatic clinical trials, please see Project Pragmatica | FDA https://lnkd.in/g-hhRvZQ

I suppose #longevity is a key item on the agenda.

Last week, we announced the exciting news, that together with the unwavering support of our project partners, we had sustainably improved the lives of 22.8 million people around the world! 👏   But what exactly does it mean to sustainably improve lives? For Croda Foundation, this means creating long-term resilience in underserved communities through projects that are replicable, scalable and measurable.   To understand the Foundation's approach in more detail, please watch this short video. 🎥 #crodafoundation #improvinglives #sustainability

5 years ago, Novo Nordisk, the manufacture of Ozempic, had a market capitalization of $60B. Today it is nearly 5x that amount at $330B. GLP-1 has also disrupted other companies such as Dexcom, a manufacturer of continuous glucose monitoring devices, who has seen its stock fall by nearly 50% from highs this year. The topic was even brought up on the The Howard Stern Show show where he asked Arnold Schwarzenegger what he thought about the Ozempic wave. Arnold’s response was essentially saying that it is the easy way out. He mentioned that real growth and progress (in people) happens during the struggle. “The human mind can only grow through resistance…Accept pain, misery, and discomfort - the more you can accept that, the more you can grow.” He continues on - “….Was this country built by people who slept in? People who are whimping out?… Don’t start to create a generation of whimps…Let’s not over baby the kids.. let’s go and teach kids to be tough, do sports, to study, to struggle and to go through painful moments sometimes..” Clearly, these drugs are controversial. The growth of GLP-1 drugs is disrupting several sectors of the industry. Where you do stand on Ozempic and other GLP-1 based drugs? Do you agree with Arnold’s assessment of the modern state of American society who are looking for the easy way out and avoiding the struggle? Let me know below. 👇 #glp1 #ozempic #nation #of #whimps #howardstren #arnold #terminator #growth #selfcare #weightloss 

🤝 Building Trust: The Heart of Our Partnerships🤝 Hello LinkedIn community, As we wrap up this week's journey through Nandan Therapeutics' core values, we save the best for last: 'Trust'. Trust is the cornerstone of every successful relationship, and it's a value we hold close to our hearts. 🌐 Trust is earned through consistent actions, open communication, and a commitment to doing what's right. At Nandan, we believe in fostering trust not just within our organization, but also with our clients, partners, and the larger community. 🤝 Our collaborations are built on a foundation of trust. We value the power of partnership and recognize that together, we can achieve remarkable feats that impact lives positively. 🔍 Trust extends beyond business—it's about building a network of authentic relationships that stand the test of time. By prioritizing trust, we create an environment where individuals can thrive, innovate, and excel. As we conclude our week of exploring core values, we invite you to reflect: How do you cultivate trust in your professional and personal connections? Share your thoughts, experiences, and insights as we continue to learn from one another. Thank you for joining us on this meaningful journey through innovation, quality, reliability, consistency, ethical & honest practices, and trust. We look forward to many more conversations and collaborations in the future! #NandanTherapeutics #Trust #Partnerships #Collaboration #ValuesMatter #WeekOfValues

The Best Medicine is a Stronger PBS For over 75 years Australians have been receiving medicines through the PBS. The PBS is a vital part of Australia's healthcare system, but it needs to be updated to keep pace with the latest medical science. AstraZeneca believes that all Australians deserve timely access to medicines that can improve their lives. As a leading biopharmaceutical company, AstraZeneca is committed to working with the government and other stakeholders to ensure that the PBS can continue to provide Australians with access to the medicines they need. "AstraZeneca is committed to working with the Australian government to ensure Australians have reimbursed access to the medicines they need," said Ben McDonald, AstraZeneca Australia and New Zealand Country President. "We believe that the #StrongerPBS campaign is important to demonstrate how important reimbursed access is and how the PBS should now evolve to support access to new medicines." We encourage you to learn more about the #StrongerPBS campaign and join us in advocating for a stronger and more sustainable PBS for all Australians. You can find more information at https://lnkd.in/eWidU3xa

Invitation to Collaborate on Community Driven Innovation for Disease Communities (CDI) Leaders of Disease Communities and Cohorts, At Genetic Alliance, we are dedicated to fostering innovation that elevates all communities by providing resources at minimal to no cost. We understand that funding often focuses on specific diseases rather than supporting overarching platforms that benefit all. This can limit our collective potential to drive change and improve patient outcomes. I am reaching out to propose a collaboration that leverages the power of Community Driven Innovation (CDI), a methodology designed to streamline the process of understanding and addressing the unique challenges faced by your communities. CDI employs the latest advancements in UI/UX and social computational choice, among other techniques, to efficiently gather and prioritize community input. This approach has already garnered attention and use from NIH grantees and leading pharmaceutical companies. My son Ian Terry, a long-standing member of our community, has been instrumental in developing CDI through his company Aretetic Solutions, LLC. You can find more details about this methodology in the document here: https://lnkd.in/gSnUSBiH. So if you are interested, contact me at sterry@geneticalliance.org to express your interest and discuss specifics. Provide the name of the disease community you represent. Choose your desired level of engagement as outlined in the attached document—aiming high is encouraged! I will reply on a first-come, first-served basis to coordinate the next steps, including applying to funders you approve. We'll then patiently await approval to proceed with a tailored engagement for your community. This initiative represents an exciting opportunity to enhance patient-focused drug development and generate real-world evidence that directly benefits your communities. Thank you for considering this partnership. Together, we can achieve remarkable advancements that benefit all our communities!